| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |